Learning Objectives:
After completing this activity, the learner will be able to:
- Explain how evidence levels and treatment lines are determined in clinical practice guidelines, including the role of safety, tolerability, and feasibility in treatment recommendations.
- Implement collaborative decision-making principles when selecting depression treatments, including setting remission as a target and discussing suicide risk management with patients and families.
- Apply a stepwise approach to managing difficult-to-treat depression, incorporating appropriate medication augmentation strategies and neurostimulation techniques based on patient response and preferences.
Original Release Date: October 1, 2025
Expiration Date: October 1, 2028
Expert: Sagar Parikh, M.D.
Medical Editors: Helen Tellegen, P.M.H.N.P., Flavio Guzmán, M.D.
Relevant Financial Disclosures:
Sagar Parikh declares the following interests:
– Aifred: Contracted research
– AbbVie: Consultant
– Compass: Contracted research
– Boehringer Ingelheim: Consultant
– Sage: Contracted research
– Mensante: Consultant and stocks
– Janssen: Contracted research
– Otsuka: Consultant
All relevant financial relationships listed above have been reviewed and mitigated in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education by the Medical Academy and the Psychopharmacology Institute.
None of the other planners and reviewers for this educational activity has relevant financial relationships to disclose during the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Contact Information: For questions regarding the content or access to this activity, contact us at support@psychopharmacologyinstitute.com
Instructions for Participation and Credit:
Participants must complete the activity online within the valid credit period noted above.
Follow these steps to earn CME credit:
- View the required educational content provided on this course page.
- Complete the Post Activity Evaluation for providing the necessary feedback for continuing accreditation purposes and for the development of future activities. NOTE: Completing the Post Activity Evaluation after the quiz is required to receive the earned credit.
- Download your certificate.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
Medical Academy designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
